In reaction to the recent swirl of rumors suggesting that PharmAGRI, a U.S.-based company specializing in plant-based pharmaceuticals, intends to place an order for 10,000 Tesla Optimus humanoid robots, Tesla's CEO, Elon Musk, has publicly refuted the claim, emphasizing that the information is entirely false. At present, the Optimus robot remains in the developmental phase, and Tesla has not commenced accepting commercial orders. The company's primary emphasis is currently directed towards the research, development, and refinement of the Optimus V3 model.